These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 25088170)

  • 1. Aortic transgraft hemorrhage after intravenous tissue plasminogen activator therapy in patients with acute ischemic stroke.
    Kawano T; Kajimoto K; Higashi M; Minatoya K; Toyoda K; Nagatsuka K
    J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2145-2150. PubMed ID: 25088170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated international normalized ratio as a manifestation of post-thrombolytic coagulopathy in acute ischemic stroke.
    Lee VH; Conners JJ; Cutting S; Song SY; Bernstein RA; Prabhakaran S
    J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2139-2144. PubMed ID: 25081309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen concentrate replacement in ischemic stroke patients after recombinant tissue plasminogen activator treatment.
    Vandelli L; Marietta M; Trenti T; Varani M; Bigliardi G; Rosafio F; Dell'acqua ML; Picchetto L; Nichelli P; Zini A
    Adv Clin Exp Med; 2019 Feb; 28(2):219-222. PubMed ID: 30507073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (> or =80 years) stroke patients.
    Berrouschot J; Röther J; Glahn J; Kucinski T; Fiehler J; Thomalla G
    Stroke; 2005 Nov; 36(11):2421-5. PubMed ID: 16210554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the Primary Imaging Modality-Computed Tomography or Magnetic Resonance Imaging-Influence Stroke Physicians' Certainty on Whether or Not to Give Thrombolysis to Randomized Acute Stroke Patients?
    Hansen CK; Christensen A; Rodgers H; Havsteen I; Kruuse C; Christensen H
    J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):926-935. PubMed ID: 29198901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator.
    Bissig D; Manjunath R; Traylor BR; Richman DP; Ng KL
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):e102-e104. PubMed ID: 28416406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of Intravenous Thrombolysis among Stroke Patients Taking New Oral Anticoagulants--Case Series and Systematic Review of Reported Cases.
    Shahjouei S; Tsivgoulis G; Bavarsad Shahripour R; Jones GM; Alexandrov AV; Zand R
    J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2685-93. PubMed ID: 26542821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on intravenous recombinant tissue plasminogen activator for acute ischemic stroke.
    Fugate JE; Rabinstein AA
    Mayo Clin Proc; 2014 Jul; 89(7):960-72. PubMed ID: 24775222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherosclerotic intracranial internal carotid artery calcification and intravenous thrombolytic therapy for acute ischemic stroke.
    Gocmen R; Arsava EM; Oguz KK; Topcuoglu MA
    Atherosclerosis; 2018 Mar; 270():89-94. PubMed ID: 29407893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of intravenous thrombolysis for acute ischemic stroke in Asia.
    Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP
    Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen degradation coagulopathy and bleeding complications after stroke thrombolysis.
    Matosevic B; Knoflach M; Werner P; Pechlaner R; Zangerle A; Ruecker M; Kirchmayr M; Willeit J; Kiechl S
    Neurology; 2013 Mar; 80(13):1216-24. PubMed ID: 23486872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke.
    Saposnik G; Fang J; Kapral MK; Tu JV; Mamdani M; Austin P; Johnston SC; ;
    Stroke; 2012 May; 43(5):1315-22. PubMed ID: 22308252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
    Anaissie JE; Monlezun DJ; Siegler JE; Waring ED; Dowell LN; Samai AA; George AJ; Kimbrough T; Berthaud J; Martin-Schild S
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter Study of Adverse Events After Intravenous Tissue-Type Plasminogen Activator Treatment of Acute Ischemic Stroke.
    Fernandez-Gotico H; Lightfoot T; Meighan M
    J Neurosci Nurs; 2017 Feb; 49(1):31-36. PubMed ID: 28060219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endovascular thrombectomy for acute ischemic stroke in failed intravenous tissue plasminogen activator versus non-intravenous tissue plasminogen activator patients: revascularization and outcomes stratified by the site of arterial occlusions.
    Shi ZS; Loh Y; Walker G; Duckwiler GR;
    Stroke; 2010 Jun; 41(6):1185-92. PubMed ID: 20431084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA.
    Van de Werf F; Barron HV; Armstrong PW; Granger CB; Berioli S; Barbash G; Pehrsson K; Verheugt FW; Meyer J; Betriu A; Califf RM; Li X; Fox NL;
    Eur Heart J; 2001 Dec; 22(24):2253-61. PubMed ID: 11728145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
    Skeik N; Gits CC; Ehrenwald E; Cragg AH
    Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage.
    Vandelli L; Marietta M; Gambini M; Cavazzuti M; Trenti T; Cenci MA; Casoni F; Bigliardi G; Pentore R; Nichelli P; Zini A
    J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):394-400. PubMed ID: 25497721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender Differences in Exclusion Criteria for Recombinant Tissue-Type Plasminogen Activator.
    Fredwall M; Sternberg S; Blackhurst D; Lee A; Leacock R; Nathaniel TI
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2569-2574. PubMed ID: 27618196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.